10 September 2009
Medical representatives from AstraZeneca came out top with UK doctors in a survey conducted by Doctors.net.uk.
More than 600 primary and secondary care doctors were asked to vote for representatives they valued in terms of communication skills, technical skills as well as for those they most enjoyed meeting. AstraZeneca was the most highly rated but a number of smaller firms also did well compared with the bigger companies, including Takeda, Ferring and Eisai.
The complete Top Ten are as follows: Eli Lilly, Pfizer, GlaxoSmithKline, Janssen Cilag, Sanofi-aventis, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb and Merck Sharpe & Dohme.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.